Cargando…
ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
Accumulated knowledge in the molecular processes of tumour development combined with the availability of genetically modified viruses resemble the basis for new promising cancer therapeutics. The main advantages of employing replication-competent viruses are achievement of tumour selective killing a...
Autores principales: | Ries, S, Korn, W M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746528/ https://www.ncbi.nlm.nih.gov/pubmed/11857003 http://dx.doi.org/10.1038/sj.bjc.6600006 |
Ejemplares similares
-
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
por: Geoerger, B, et al.
Publicado: (2003) -
Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells
por: Madara, Jonathan, et al.
Publicado: (2005) -
Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver
por: Au, T, et al.
Publicado: (2006) -
Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment
por: Parmar, Hamendra Singh, et al.
Publicado: (2022) -
Cellular and metabolic mechanisms of nutrient actions in immune function
por: Newsholme, Philip
Publicado: (2021)